Olaparib Price in India: — Brand, Generic and Monthly Cost

The active molecule and dose are identical. A CDSCO-approved generic has demonstrated bioequivalence to the originator, meaning it is absorbed and works in the body the same way. The excipients — fillers and coatings — may differ between manufacturers, but this rarely matters clinically. If you switch manufacturers and notice any change, tell your oncology team. For most patients, a CDSCO-approved generic is a reliable and significantly more affordable option.

Olaparib is listed in the PM-JAY Health Benefit Package for specific indications. Whether your treatment qualifies depends on your diagnosis, stage and the empanelled hospital through which you are being treated. Your CION care coordinator or hospital social worker can check your eligibility and help with the pre-authorisation process. Do not assume coverage — get written confirmation before relying on it, and do not delay purchasing if the confirmation process takes time.

Some manufacturers — both the originator and certain generic producers — run named patient or compassionate access programmes. Eligibility usually depends on income criteria, your clinical indication, and whether you have explored insurance or government scheme options first. Ask your oncologist or the hospital pharmacy which programmes they are currently aware of. These schemes change frequently, so it is worth asking at every stage of treatment rather than assuming a programme that was available before is still running.

Some policies cover oral oncology drugs; others explicitly exclude them or require a separate oncology rider. The only reliable way to know is to read your policy's schedule of benefits for the exact molecule name, or ask your insurer in writing before the prescription is filled. Pre-authorisation is often required and must be obtained before dispensing, not after. If your policy does cover it, keep all prescriptions and pharmacy receipts — insurers typically require these for reimbursement claims.

Yes, directly. Your oncologist sets the dose based on your specific cancer, the gene mutation involved, and your kidney function. A higher dose means more tablets per month and a proportionally higher monthly cost. Do not adjust your dose to reduce cost without discussing it with your oncologist — the dose is set for a clinical reason. If affordability is a concern, raise it openly so your team can explore all available options, including assistance programmes and generic substitution, before you consider any change.

Oncology drug pricing varies between pharmacies because of differences in supply chain, the manufacturer stocked, and whether the pharmacy has negotiated bulk purchasing rates. Hospital oncology pharmacies often have lower prices than retail chains because they purchase in larger volumes. Generic manufacturers also price differently from each other. Calling two or three recognised oncology pharmacies and asking for the price of olaparib by molecule name — rather than a specific brand — is a practical step before committing to the first quote you receive.